Peter Xu, Executive Director of Consun Pharmaceutical Group and Guangzhou Consun Pharmaceutical Co., LTD

Mr. Xu joined Consun Pharmaceutical Group in November 2020 and has many years of overseas systematic study and work experience in public accounting and financial management, as well as working experience in the Big Four firms.

Professor Zhu Quan is Executive Director and Chief Scientist of Consun Pharmaceutical Group, Executive Director of Guangzhou Consun Pharmaceutical Co., LTD, primarily responsible for Consun drug strategy development direction. 

Professor Zhu has over 50 years of experience in medical research.He was the former Deputy Director of the Medicine College of Nanjing University of Chinese Medicine, Director and doctoral supervisor of National Standardization Laboratory for Chinese Herbal Pharmacology (國(guó)家規(guī)范化中藥藥理實(shí)驗(yàn)室). Professor Zhu also served as an expert of Science & Technology Commission of Ministry of Education(國(guó)家教育部科學(xué)技術(shù)委員會(huì)), an assessment expert of Department of Life Science of National Natural Science Foundation(國(guó)家自然科學(xué)基金生命科學(xué)部) and a drug evaluation expert of Jiangsu Province and the People's Republic of China.

Professor Zhu graduated from the Traditional Chinese Medicine Academy (now known as the Chinese Academy of Traditional Chinese Medicine) in November 1981 and received a master's degree in traditional Chinese medicine. He has served as a professor and doctoral supervisor at Macau University of Science and Technology (澳門科技大學(xué)) since September 2003. Professor Zhu joined Consun in August 2006.

Mr. Tang Ning is Vice President of Consun Pharmaceutical Group, Executive Director of Guangzhou Consun Pharmaceutical Co., LTD., primarily responsible for Consun marketing business management. 

Mr. Tang joined Consun in July 1998 as Business Manager, Regional Marketing Manager, Marketing Director and President Assistant. He has been Vice President since June 2011 and Executive Director since June 1, 2018.

Mrs. Fang Lanfen is Vice President of Consun Pharmaceutical Group, primarily responsible for Consun policy affairs and marketing management.

Mrs. Fang joined Consun in July 1999 as Business Manager, Regional Marketing Manager, Marketing Director. She has been Vice President since July 2013. She was appointed as a member of the First Expert Committee for Chinese Medicine Development and Research for Kidney Disease of China Association of Traditional Chinese Medicine(中國(guó)中藥協(xié)會(huì)第一屆腎病中藥發(fā)展研究專業(yè)委員會(huì)) in August 2016.

Mr. Fang Peicheng is Vice President and Executive Director of Consun Pharmaceutical (Inner Mongolia) Co., LTD., primarily responsible for Consun finance and investment operation management.

Mr. Fang joined Consun in August 2010 as Audit Manager, Audit and Legal Director. He has been President Assistant since January 2015 and Director of Consun’s subsidiary Consun Pharmaceutical (Inner Mongolia) Co. Ltd since August 2018.

Mr. Fang graduated from Nan Hua College of Industry and Commerce (南華工商學(xué)院), majoring in Accounting Computerization in July 2002 and graduated from China University of Petroleum (Eastern China) (中國(guó)石油大學(xué)(華東)) Accounting Profession with a bachelor’s degree in management in July 2008. Mr. Fang has the Audit Professional Qualification Certificate (Intermediate) granted by the Ministry of Human Resources and Social Security of the People’s Republic of China (中華人民共和國(guó)人力資源和社會(huì)保障部). He is also a member of the Institute of Internal Auditors.

Mark Li  Vice President of Consun Pharmaceutical Group, General Manager of Guangzhou Consun Pharmaceutical Research Co., LTD., Executive Director of Guangzhou Consun Pharmaceutical Co., LTD

Responsible for Consun drug strategic research and development and scientific and technological innovation, and overall management of drug research and development. Mrs. Li joined Conson Pharmaceutical Group in April 2019 and has been engaged in R&D management for nearly 30 years.

Wang Changzhu  Director of the CEO’s Office of Consun Pharmaceutical Group

Responsible for overall management of the CEO's Office.

Joined Consun Pharmaceutical Group in December 2021, with nearly 20 years of practical experience in comprehensive operation and management in Top 500 foreign-funded enterprises.

Mr. Yau Chi Ming is Company Secretary of Consun Pharmaceutical Group, primarily responsible for the board of directors, shareholders conferences and securities related foreign matters.

Mr. Yau has over 20 years of experience in finance and accounting. Mr. Yau joined Consun in March 2013 as Company Secretary. Mr. Yau once worked at an international audit firm from August 1992 to November 1994 and from May 1995 to October 2012.

Mr. Yau graduated from The University of Hong Kong in 1992 with a bachelor’s degree in Social Sciences. Mr. Yau is a certified public accountant and a senior member of the Hong Kong Institute of Certified Public Accountants.

Mr. Gao Haien is Board Secretary of Consun Pharmaceutical Group, Executive Director of Consun Pharmaceutical (Inner Mongolia) Co., LTD.and Guangxi Yulin Pharmaceutical Group Co., LTD. Executive Director and General Manager of Consun Pharmaceutical (Horgos) Co., LTD. Mr. Gao assists in coordinating the board of directors, shareholders conferences and securities related domestic matters.

Mr. Gao joined Consun in August 2007 as the Board Secretary. Mr. Gao has been the legal representative of Consun’s subsidiaries Guangzhou Consun Pharmaceutical Co. Ltd, Consun Pharmaceutical (Inner Mongolia) Co. Ltd and Inner Mongolia Kangyuan Pharmaceutical Co. Ltd since March 2013. Mr. Gao has been Director of Consun’s subsidiary Consun Pharmaceutical (Inner Mongolia) Co. Ltd since August 2018.

Mr. Gao graduated from China University of Mining and Technology with a bachelor's degree in engineering in 1992 and a bachelor's degree in economics in 1994. He obtained his MBA from Zhongnan University of Economics and Law in 2012. Mr. Gao has Securities Professional Qualification Certificate (Level 2) issued by the Securities Association of China and Board Secretary Qualification Certificate issued by Shenzhen Stock Exchange. He is also a member of Hong Kong Securities and Investment Institute. 

Liu Zunlu, Director of Production Department of Consun Pharmaceutical Group, General Manager of Guangzhou Base

Responsible for the comprehensive management of Consun Production Department and Guangzhou base;

Joined Consun Pharmaceutical Group in June 2021, with over 20 years of production technology management experience.

Mrs. Chen Lianhui is mainly responsible for the daily affairs management of Consun Pharmaceutical (Inner Mongolia) Co. Ltd. and Consun Pharmaceutical (Horgos) Co., LTD.She joined Consun in March 2001 and served as Deputy Manager of Quality Management Department, Logistics Director and General Manager of Inner Mongolia successively. In August 2018, she served as Chairman and General Manager of Consun Pharmaceutical (Inner Mongolia) Co. Ltd. She has over 30 years of experience in pharmaceutical industry.

Mr. Guo Guorong is mainly responsible for the comprehensive management of Yulin Pharmaceutical Co. Ltd. He joined Consun in November 2012 as Production Director. In July 2016, he served as Executive Deputy General Manager of Guangxi Yulin Pharmaceutical Group. In July 2018, he served as Chairman and General Manager of Guangxi Yulin Pharmaceutical Group. He has nearly 30 years of experience in pharmaceutical industry.